0%
Regulatoryregulatorystem-cell-therapy

Florida HB 1617 - Stem Cell Therapy Authorization

Florida Legislature

Florida HB 1617 authorizes physicians to perform FDA-unapproved stem cell therapy with specific requirements for manufacturing practices, patient consent, and advertising disclosures. Effective July 1, 2025.

AI generated image for: Florida HB 1617 - Stem Cell Therapy Authorization
Florida Senate Bill 1617 - Stem Cell Therapy Authorization

This legislation establishes the regulatory framework for stem cell therapy authorization in Florida healthcare facilities. The bill addresses the growing need for clear guidelines in regenerative medicine practices.

Key Provisions
  • Establishes authorization requirements for stem cell therapy providers
  • Creates oversight mechanisms for patient safety
  • Defines regulatory compliance standards for healthcare facilities

Research Details

Source

Florida Legislature

Publication Date
Categories & Tags
Regulatoryregulatorystem-cell-therapy

Cite this article: Florida Legislature. "Florida HB 1617 - Stem Cell Therapy Authorization". Published August 21, 2025. Available at: https://www.flsenate.gov/Session/Bill/2025/1617

Access Original Research

View the complete study and detailed methodology from the original source.

Read Full Study